Has Opko ruined BRLI and itself? Since the purchase, shares have sunk and BRLI profits have evaporated. Is this just natural selection or is Opko management as incompetent in the lab sector as analysts are starting to realize? Wasn’t the purchase based off 4K potential? Since 4K is essentially dead in the water, will a sell of BRLI happen or will Opko’s failures in the drug sector force Opko to milk what they can from BRLI until it’s done? Questions are mounting for next earnings call.
